BC
PTCT icon

Burney Company’s PTC Therapeutics PTCT Stock Holding History

Burney Company’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04M Buy
37,320
+21,708
+139% +$1.57M 0.08% 185
2026
Q1 		$1.06M Sell
15,612
-10,957
-41% -$776K 0.03% 323
2025
Q4 		$2.02M Buy
+26,569
New +$1.93M 0.06% 241
2024
Q2 		– Sell
-42,040
Closed -$1.22M – 611
2024
Q1 		$1.22M Buy
+42,040
New +$1.18M 0.05% 298

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Burney Company's PTCT Position: Q2 2026 in Review

Burney Company increased its PTC Therapeutics (PTCT) stake by 139% in Q2 2026, buying an estimated $1.57M and bringing the position to 37,320 shares worth $3.04M. The position accounts for 0.08% of the portfolio, ranked #185.

Burney Company first reported a position in PTCT in Q1 2024 and has held it in 4 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Burney Company held 37,320 shares of PTC Therapeutics worth $3.04M as of Q2 2026.
  • Burney Company bought 21,708 PTC Therapeutics shares in Q2 2026, an estimated $1.57M.
  • PTC Therapeutics made up 0.08% of Burney Company's portfolio in Q2 2026, its #185 holding.
  • Burney Company first reported a position in PTC Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Burney Company's 13F filing for Q2 2026, filed 15 Jul 2026.